These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 33910208

  • 21. Sildenafil inhibits hypoxia-induced pulmonary hypertension.
    Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR.
    Circulation; 2001 Jul 24; 104(4):424-8. PubMed ID: 11468204
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
    Dong F, Zhang J, Zhu S, Lan T, Yang J, Li L.
    J Cardiovasc Pharmacol; 2019 Nov 24; 74(5):426-435. PubMed ID: 31725079
    [Abstract] [Full Text] [Related]

  • 27. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
    Jasińska-Stroschein M, Owczarek J, Wesołowska A, Orszulak-Michalak D.
    Acta Pharm; 2014 Sep 24; 64(3):345-53. PubMed ID: 25296680
    [Abstract] [Full Text] [Related]

  • 28. Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.
    Tual L, Morel OE, Favret F, Fouillit M, Guernier C, Buvry A, Germain L, Dhonneur G, Bernaudin JF, Richalet JP.
    Pflugers Arch; 2006 Jul 24; 452(4):371-9. PubMed ID: 16639551
    [Abstract] [Full Text] [Related]

  • 29. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.
    Vascul Pharmacol; 2018 Jan 24; 100():41-50. PubMed ID: 29100963
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y, Wang W, Chai S, Liu J, Yang T, Wang J.
    Exp Biol Med (Maywood); 2015 Dec 24; 240(12):1742-51. PubMed ID: 25956683
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J, Kukucka M, Hoffmann J, Sterner-Kock A, Burhenne J, Haefeli WE, Kuppe H, Kuebler WM.
    Circ Heart Fail; 2011 Mar 24; 4(2):198-206. PubMed ID: 21216837
    [Abstract] [Full Text] [Related]

  • 34. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
    Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ.
    Am J Physiol Heart Circ Physiol; 2013 Nov 01; 305(9):H1288-96. PubMed ID: 23997103
    [Abstract] [Full Text] [Related]

  • 35. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K, Vasconcelos-Silva AA, Rodrigues-Silva MJ, Rebouça CDSM, Duarte GP, Borges RS, Magalhães PJC, Lahlou S.
    Eur J Pharmacol; 2021 Apr 15; 897():173948. PubMed ID: 33609564
    [Abstract] [Full Text] [Related]

  • 36. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
    MacRitchie N, Volpert G, Al Washih M, Watson DG, Futerman AH, Kennedy S, Pyne S, Pyne NJ.
    Cell Signal; 2016 Aug 15; 28(8):946-55. PubMed ID: 27063355
    [Abstract] [Full Text] [Related]

  • 37. Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
    Andersen CU, Mulvany MJ, Simonsen U.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):87-96. PubMed ID: 15740728
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S, Houssaïni A, Mouraret N, Marcos E, Amsellem V, Wan F, Dubois-Randé JL, Derumeaux G, Boczkowski J, Motterlini R, Adnot S.
    Arterioscler Thromb Vasc Biol; 2014 Feb 07; 34(2):304-12. PubMed ID: 24334871
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.